Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response.
Molecules. 2020 Dec 19;25(24):6029. doi: 10.3390/molecules25246029.
Molecules. 2020.
PMID: 33352773
Free PMC article.
PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma.
Lee H, Riad A, Martorano P, Mansfield A, Samanta M, Batra V, Mach RH, Maris JM, Pryma DA, Makvandi M.
Lee H, et al.
J Nucl Med. 2020 Jun;61(6):850-856. doi: 10.2967/jnumed.119.233965. Epub 2019 Nov 1.
J Nucl Med. 2020.
PMID: 31676730
Free PMC article.
Item in Clipboard
PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of Glioblastoma.
Dabagian H, Taghvaee T, Martorano P, Martinez D, Samanta M, Watkins CM, Chai R, Mansfield A, Graham TJ, Maris JM, Pryma DA, Mach RH, Makvandi M.
Dabagian H, et al.
ACS Pharmacol Transl Sci. 2021 Jan 26;4(1):344-351. doi: 10.1021/acsptsci.0c00206. eCollection 2021 Feb 12.
ACS Pharmacol Transl Sci. 2021.
PMID: 33615184
Free PMC article.
Item in Clipboard
Imatinib alleviates lung injury and prolongs survival in ventilated rats.
Xin Y, Cereda M, Yehya N, Humayun S, Delvecchio P, Thompson JM, Martin K, Hamedani H, Martorano P, Duncan I, Kadlecek S, Makvandi M, Brenner JS, Rizi RR.
Xin Y, et al.
Am J Physiol Lung Cell Mol Physiol. 2022 Jun 1;322(6):L866-L872. doi: 10.1152/ajplung.00006.2022. Epub 2022 Apr 19.
Am J Physiol Lung Cell Mol Physiol. 2022.
PMID: 35438574
Free PMC article.
Item in Clipboard
Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma.
Batra V, Samanta M, Makvandi M, Groff D, Martorano P, Elias J, Ranieri P, Tsang M, Hou C, Li Y, Pawel B, Martinez D, Vaidyanathan G, Carlin S, Pryma DA, Maris JM.
Batra V, et al.
Clin Cancer Res. 2022 Sep 15;28(18):4146-4157. doi: 10.1158/1078-0432.CCR-22-0400.
Clin Cancer Res. 2022.
PMID: 35861867
Free PMC article.
Item in Clipboard
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma.
Makvandi M, Samanta M, Martorano P, Lee H, Gitto SB, Patel K, Groff D, Pogoriler J, Martinez D, Riad A, Dabagian H, Zaleski M, Taghvaee T, Xu K, Lee JY, Hou C, Farrel A, Batra V, Carlin SD, Powell DJ Jr, Mach RH, Pryma DA, Maris JM.
Makvandi M, et al.
Commun Biol. 2022 Nov 17;5(1):1260. doi: 10.1038/s42003-022-04209-8.
Commun Biol. 2022.
PMID: 36396952
Free PMC article.
Item in Clipboard
In vitro characterization of [125I]HY-3-24, a selective ligand for the dopamine D3 receptor.
Lee JY, Kim HY, Martorano P, Riad A, Taylor M, Luedtke RR, Mach RH.
Lee JY, et al.
Front Neurosci. 2024 Apr 9;18:1380009. doi: 10.3389/fnins.2024.1380009. eCollection 2024.
Front Neurosci. 2024.
PMID: 38655111
Free PMC article.
Item in Clipboard
Cite
Cite